Astera Labs, Inc. (NASDAQ:ALAB) Stock Has Average Target Price of $348.33 According to Analysts

Astera Labs, Inc. (NASDAQ:ALAB) has received a consensus recommendation of “Moderate Buy” from the twenty-one research firms that are currently covering the firm, Marketbeat.com reports. Eight equities research analysts have rated the stock with a hold recommendation, twelve have given a buy recommendation and one has given a strong buy recommendation to the company. The average 1-year price target among brokers that have issued ratings on the stock in the last year is $348.33.

A number of equities research analysts have recently commented on the company. Bank of America increased their target price on Astera Labs from $240.00 to $450.00 and gave the stock a “neutral” rating in a research note on Tuesday, June 23rd. Roth Capital reiterated a “buy” rating and issued a $450.00 price target on shares of Astera Labs in a research note on Wednesday, August 5th. Northland Securities raised shares of Astera Labs from a “market perform” rating to an “outperform” rating and set a $350.00 price objective on the stock in a research report on Monday, August 17th. Susquehanna raised their price objective on shares of Astera Labs from $230.00 to $275.00 and gave the company a “neutral” rating in a research note on Friday, July 31st. Finally, Barclays lifted their target price on shares of Astera Labs from $200.00 to $325.00 and gave the stock an “equal weight” rating in a report on Monday, July 20th.

Astera Labs Price Performance

Shares of Astera Labs stock opened at $350.33 on Friday. Astera Labs has a 52 week low of $97.89 and a 52 week high of $499.48. The business has a 50 day moving average of $309.04 and a 200 day moving average of $283.09. The company has a market cap of $60.78 billion, a PE ratio of 173.43 and a beta of 3.68.

Astera Labs (NASDAQ:ALAB) last posted its quarterly earnings data on Tuesday, August 4th. The company reported $0.80 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.69 by $0.11. Astera Labs had a return on equity of 19.24% and a net margin of 30.74%.The business had revenue of $392.40 million during the quarter, compared to the consensus estimate of $360.85 million. During the same quarter in the prior year, the company earned $0.44 earnings per share. The firm’s quarterly revenue was up 104.5% compared to the same quarter last year. Astera Labs has set its Q3 2026 guidance at 1.160-1.210 EPS. On average, research analysts anticipate that Astera Labs will post 2.7 earnings per share for the current year.

Insiders Place Their Bets

In other Astera Labs news, CEO Jitendra Mohan sold 90,630 shares of the firm’s stock in a transaction dated Monday, August 17th. The stock was sold at an average price of $340.35, for a total value of $30,845,920.50. Following the transaction, the chief executive officer directly owned 1,266,665 shares of the company’s stock, valued at approximately $431,109,432.75. This trade represents a 6.68% decrease in their ownership of the stock. The sale was disclosed in a document filed with the SEC, which is accessible through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards. Also, Director Manuel Alba sold 183,000 shares of the firm’s stock in a transaction dated Tuesday, September 1st. The stock was sold at an average price of $280.13, for a total value of $51,263,790.00. Following the completion of the transaction, the director directly owned 253,863 shares in the company, valued at $71,114,642.19. This trade represents a 41.89% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders sold a total of 396,059 shares of company stock worth $122,605,660 in the last three months. Corporate insiders own 10.40% of the company’s stock.

Hedge Funds Weigh In On Astera Labs

Several large investors have recently made changes to their positions in ALAB. QRG Capital Management Inc. grew its stake in Astera Labs by 8.7% during the second quarter. QRG Capital Management Inc. now owns 4,775 shares of the company’s stock valued at $2,306,000 after acquiring an additional 381 shares in the last quarter. Silicon Valley Capital Partners increased its stake in Astera Labs by 99.0% during the second quarter. Silicon Valley Capital Partners now owns 1,990 shares of the company’s stock worth $961,000 after acquiring an additional 990 shares during the last quarter. Twin Peaks Capital Ltd purchased a new stake in Astera Labs during the second quarter valued at approximately $4,830,000. Capstone Financial Advisors Inc. purchased a new stake in Astera Labs during the second quarter valued at approximately $274,000. Finally, Sequoia Financial Advisors LLC lifted its stake in shares of Astera Labs by 19.0% in the 2nd quarter. Sequoia Financial Advisors LLC now owns 3,677 shares of the company’s stock valued at $1,776,000 after purchasing an additional 588 shares during the last quarter. 60.47% of the stock is currently owned by hedge funds and other institutional investors.

Astera Labs Company Profile

Astera Labs, Inc is a fabless semiconductor company that develops connectivity solutions for cloud and artificial intelligence infrastructure. Its products are designed to help data centers connect and manage processors, memory, storage, and networking components in high-performance computing systems.

The company’s portfolio includes Aries PCI Express and Compute Express Link (CXL) smart memory controllers, Scorpio PCIe switches, Taurus Ethernet fabric switches, and Leo CXL memory connectivity products.